Live from the NIH registry
Studies recruiting near McAllen right now
Top 25 of 137 recruiting studies, sorted by proximity — each links to its official registry page
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Valley Retina Institute, PA — McAllen, Texas (1.8 mi)
· Sponsor: Boehringer Ingelheim
A Randomized Control Trial of Conversations Advancing Resilience and Empowerment (CARE) Intervention
Quality of Life, Health Promotion
N/A
Interventional 200 participants sought
The University of Texas at Rio Grande Valley — Edinburg, Texas (7.4 mi)
· Sponsor: University of Texas Rio Grande Valley
A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
Hypoparathyroidism
Phase 3
Interventional 160 participants sought
MBX Biosciences Investigational Site — Weslaco, Texas (16.5 mi)
· Sponsor: MBX Biosciences
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Texas Valley Clinical Research /ID# 261476 — Weslaco, Texas (16.5 mi)
· Sponsor: AbbVie
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Biopharma Informatic-McAllen — McAllen, Texas (1.8 mi)
· Sponsor: Amgen
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Texas Oncology - Central/South Texas — McAllen, Texas (1.8 mi)
· Sponsor: Pfizer
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
COVID-19
Phase 3
Interventional 160 participants sought
Biopharma Informatic, LLC — McAllen, Texas (1.8 mi)
· Sponsor: Pfizer
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Edinburg, Texas (7.4 mi)
· Sponsor: 89bio, Inc.
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
Valley Retina Institute- McAllen (01076) — McAllen, Texas (1.8 mi)
· Sponsor: Apellis Pharmaceuticals, Inc.
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
Biopharma Informatic LLC — McAllen, Texas (1.8 mi)
· Sponsor: Boehringer Ingelheim
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Phase 3
Interventional 698 participants sought
A & A Research Consultants, LLC — McAllen, Texas (1.8 mi)
· Sponsor: United Therapeutics
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — McAllen, Texas (1.8 mi)
· Sponsor: Alnylam Pharmaceuticals
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Overweight, Obesity
Phase 3
Interventional 900 participants sought
Texas Valley Clinical Research (TVCR) - Mission — Mission, Texas (4.9 mi)
· Sponsor: Eli Lilly and Company
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Myositis
Phase 3
Interventional 318 participants sought
Pulmonary and Sleep Center of the Valley — Weslaco, Texas (16.5 mi)
· Sponsor: Pfizer
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Breast Cancer, Metastatic Breast Cancer
Phase 3
Interventional 404 participants sought
Texas Oncology McAllen — McAllen, Texas (1.8 mi)
· Sponsor: BriaCell Therapeutics Corporation
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Obesity, Overweight
Phase 2
Interventional 1,481 participants sought
Texas Valley Clinical Research — Weslaco, Texas (16.5 mi)
· Sponsor: Eli Lilly and Company
Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers
Diabetic Foot Ulcer, Wagner Grade 1 - 2
Phase 1, Phase 2
Interventional 15 participants sought
Futuro Clinical Trials — McAllen, Texas (1.8 mi)
· Sponsor: Eluciderm Inc
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Phase 3
Interventional 1,200 participants sought
Research Site — Weslaco, Texas (16.5 mi)
· Sponsor: AstraZeneca
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
Respiratory Syncytial Virus Infections
Phase 2
Interventional 192 participants sought
DCT-McAllen Primary Care Research, LLC — McAllen, Texas (1.8 mi)
· Sponsor: Shionogi
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
DHR Health Advance Care Center — Edinburg, Texas (7.4 mi)
· Sponsor: Guardant Health, Inc.
A Study of Pitolisant in Patients With Prader-Willi Syndrome
Prader-Willi Syndrome
Phase 3
Interventional 134 participants sought
Texas Valley Clinical Research — Weslaco, Texas (16.5 mi)
· Sponsor: Harmony Biosciences Management, Inc.
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Osteoarthritis, Overweight or Obesity
Phase 3
Interventional 900 participants sought
Texas Valley Clinical Research — Weslaco, Texas (16.5 mi)
· Sponsor: Eli Lilly and Company
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Multiple Sclerosis
Phase 4
Interventional 100 participants sought
DHR Health MS Center — McAllen, Texas (1.8 mi)
· Sponsor: Genentech, Inc.
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
Gamma Medical Research, Inc. — McAllen, Texas (1.8 mi)
· Sponsor: CSL Behring
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
Non Small Cell Lung Cancer
Phase 3
Interventional 630 participants sought
Texas Oncology - McAllen - 1132 — McAllen, Texas (1.8 mi)
· Sponsor: OncoC4, Inc.